Reimagining the regulation of informal pharmaceutical markets: The importance of pragmatic expertise and improvisation in Nigeria

Drug-induced upper gastrointestinal bleeding: A real-world pharmacovigilance study

MHRA Drug Safety Update: Falsified Mounjaro KwikPen 15mg pre-filled pens

Puberty blockers: Controversial trial paused over safety concerns

Redefining polypharmacy: Shifting from drug counts to patient-centered clinical appropriateness

Long‐Term Adherence and Drug Utilisation Patterns Among New Users of Anti‐Hyperlipidemic Monotherapy: Development of a Risk Prediction Model

Cómo la Industria Farmacéutica Influye en la Producción de Evidencias Científicas: Manipulación de Investigaciones y Escritura Fantasma (ghostwriting)

Systematic modeling predicts synergistic and safe drug combinations for parasitic diseases

Prospective Study of Adverse Drug Reactions in Patients with Bipolar Disorder at a tertiary centre

Potential utility of social media in pharmacovigilance to identify adverse events and safety signals: a scoping review

Aquatic ecotoxicology in a climate change scenario to support ecopharmacovigilance of veterinary antibiotics

Digital medicine for infectious diseases

Comparison of Adverse Events Associated With Six Common Antibiotics in Lower Respiratory Tract Infections Using the United States Food and Drug Administration Adverse Event Reporting System

Contributions of Pharmacovigilance to the Understanding of Risks Associated with Ibuprofen: Descriptive and Disproportionality Analysis Using FAERS Data

Artificial Intelligence for Drug Safety Across the Lifecycle and Decision Type: A Scoping Review

Comparative disproportionality signals for methotrexate monotherapy versus methotrexate combined with hydroxychloroquine, leflunomide, or sulfasalazine in rheumatoid arthritis: newly highlighted signals evaluated using drug information safety profiles

Dosis letal: cómo se mide la seguridad de un medicamento

Potential risk signals for drug-related osteomyelitis: a comprehensive disproportionality analysis based on the FDA Adverse Event Reporting System (FAERS) database

A pharmacovigilance analysis of carbapenem-related utilizing the FDA adverse event reporting system (FAERS) database from 2013 to 2025

Exploratory analysis of real-world use and safety of traditional Korean medicine in pediatric epilepsy: A retrospective observational study

Prenatal exposure to antiseizure medications and risk of autism spectrum disorder in offspring: an integrated pharmacovigilance and two-sample mendelian randomization study

Navigating drug–drug interactions with apalutamide

Artificial intelligence-based incident analysis and learning system to enhance patient safety and improve treatment quality

Selective oestrogen receptor modulators and Alzheimer´s disease: a real-world pharmacovigilance study

Unveiling the hidden risks of nanomedicine-based drug delivery: a comparative evaluation of drug safety profiles of liposomal irinotecan and conventional irinotecan

Empowering citizens to spontaneously report suspected adverse drug reaction: Systematic literature review of interventions and their impact

Assessing safety trends of withdrawn medications: A data-driven pharmacovigilance approach using growth models

Analysis of interstitial lung disease in pharmacovigilance databases: Coding challenges and interpretation biases—An update

Fondos Rotatorios: un mecanismo clave para garantizar la disponibilidad y seguridad de vacunas y medicamentos en el Perú

Navigating Polypharmacy: A Patient-Focused Guide to Safer Medication Use

What if most medications were sold over-the-counter?

Complex Link Between Drug Prices and Health Plan Coverage

Anabolic Steroid Misuse Damages Heart, Liver, Kidneys, and Brain

Chlorhexidine vs Povidone-Iodine and Incidence of Catheter-Related Infections. A Systematic Review and Meta-Analysis

Mechanisms Are Emerging for COVID-19 Vaccine−Associated Myocarditis

Using the advantages and avoiding the risks – a public survey about the challenges of online purchases of medicines

Disparities and trends in drug-related adverse reaction mortality in the United States, 1999–2020

Safety communication unveiled: A comprehensive bibliometric analysis spanning two decades (2001-2023)

Subacute Cutaneous Lupus Erythematosus Following COVID-19 Vaccination: A Case Report after BNT162b2 Vaccine and Literature Review

Guideline Adherence of Perioperative Antibiotics and Surgical Site Infections in Noncardiac Surgery

Pharmacist Intervention for Safer Prescribing in Patients With Type 2 Diabetes at High Risk. A Randomized Clinical Trial

Farmacovigilância: causas da subnotificação por profissionais de saúde e estratégias para redução

Performance of the Self-Controlled Case Series for Drug Safety Signal Detection: A Multi-Database Study

Comparing Paracetamol and Ibuprofen Safety in Infant Care

Desinformación en salud: un desafío estructural que exige una estrategia transversal

Drugs associated the most with Retroperitoneal Fibrosis: assessment of the 1969-2025 Food and Drug Administration (FDA) pharmacovigilance database

Good News for Patients Worried About Statin Side Effects: Study Finds Most Never Happen

Statin safety: when warnings outlive the evidence

EMA recommends withdrawal of marketing authorisations for levamisole medicines

The ASCEND Project (2020-2023): Strengthening clinical trial ethics review and pharmacovigilance capacity in Tanzania mainland and Zanzibar

AI-Enabled Surveillance and Modelling for Counterfeit Botulinum Toxin A: Risk Projection, Patient Safety, and Systemic Reform of Pharmacovigilance

Development and validation of a machine learning stratified prediction model for early warning of anti-tuberculosis drug-induced liver injury risk based on real-world data: a retrospective cohort study

20 million illegal erectile dysfunction pills seized as MHRA warns against risky online buys

Efficacy and safety of different inhaler types for asthma and chronic obstructive pulmonary disease. a systematic review and meta-analysis

Biochemical profiling provides a low-cost and globally accessible method to detect falsified vaccines and insulin

A framework for enhancing pharmaceutical integrity and patient safety: novel mobile health solution integrating smart packaging and computer vision

Drugs Associated with Pediatric Cataracts: A Real-World Pharmacovigilance Study

El Hospital Regional de Málaga alerta del reto del Paracetamol entre menores, que puede causar la muerte

A Review Harnessing Artificial Intelligence for Enhanced Pharmacovigilance

A Short Overview of Using Artificial Intelligence in Pharmacovigilance

Analysis of the Adverse Event Profiles of Medications for Alcohol Use Disorder: Insights from a Japanese Pharmacovigilance Database

Early Detection of Absurdity Signals in Pharmacovigilance: A Machine Learning Ensemble Approach to Identify Rare Adverse Drug Reactions

Artificial intelligence-based incident analysis and learning system to enhance patient safety and improve treatment quality

Further information on Post authorisation monitoring – Pharmacovigilance

Ministerio de Salud intensifica lucha frontal contra la falsificación de medicamentos

Drug-drug interaction, adverse drug reaction and their determinants among adult hypertensive patients; Multicenter study in Ethiopia

Age and Gender Heterogeneity in Adverse Drug Reactions Associated with Hemp Use: Evidence from the FDA Pharmacovigilance Data in the Last Two Decades

Artificial Intelligence and Machine Learning in Pharmacovigilance: A Systematic Review of Models for Drug Safety in Polypharmacy

Evaluating adverse events reported for non-steroidal anti-inflammatory drugs in osteoarthritis: a real-world pharmacovigilance study

Medication Concerns: Driving Factors in High-Risk Adults

La AEMPS informa del cambio de dosificación de Rybelsus (semaglutida) y los posibles errores de medicación

El CGCOF y la AEMPS lanzan una campaña para fomentar la notificación de reacciones adversas de los medicamentos

Safety population size and duration of exposure prior to approval of new medicines: A database analysis of medicines centralised approved in the European Union between 2011 and 2023

Veterinary drug residues in food: what’s the latest in the EU?

 

IXCHIQ Chikungunya vaccine: updates to restrictions of use following safety review

Las especialistas en Farmacología Clínica, claves para garantizar la seguridad de los medicamentos y la equidad en los ensayos clínicos

What drugs are safe during pregnancy? There’s a shocking lack of data

Impact of the amended CIR 520/2012 to UK authorised products

Updates to CIR 520/2012 – Information for UK Marketing Authorisation Holders

Clinicians and pharmacists – Are your patients aware of the risks of buying melatonin online?

Europa se estanca en la reducción de residuos de medicamentos veterinarios: más controles, pero mismos resultados

EsSalud refuerza la vigilancia de medicamentos y dispositivos médicos para prevenir riesgos en pacientes

Phosphorescent supramolecular systems for medicine anticounterfeiting

Seis boticas clausuradas por venta irregular de medicamentos

Prescribing Patterns of Potentially Inappropriate CNS-Active Medications in Older Adults

Large language models-powered agentic AI design and implementation in pharmacovigilance—a narrative review

Older Patients Have Specific Risks for GLP-1 Use

Artificial Intelligence in Food Allergy and Drug Allergy

Respiratory drugs and psychiatric adverse events in children and adolescents: a pharmacovigilance study based on the FAERS database

Proton Pump Inhibitors and Disproportionate Reporting of Acute Kidney Injury and Tubulointerstitial Nephritis: A FAERS Pharmacovigilance Study, 2020–2025

Safety Assessment of Budesonide/Formoterol: Real-World Pharmacovigilance Analysis Using the FAERS, JADER, and CVAR Databases

Real-World Sodium Fluoride Safety Signals: Dual-Database Pharmacovigilance

Assessing patient risk, benefit, and outcomes in drug development: a decade of sorafenib clinical trials

La AEMPS informa sobre el riesgo de acontecimientos adversos en animales de compañía por contacto con medicamentos hormonales tópicos de humanos

Computational modelling and network medicine in drug toxicology and clinical pharmacovigilance

When Silence Signals Safety: Governance and Responsibility in AI-Enabled Prescription Verification

Update of the statement on safety of cannabidiol as a novel food

Por qué la seguridad está redefiniendo la política del medicamento

FDA Intends to Take Action Against Non-FDA-Approved GLP-1 Drugs

Adverse Drug Reactions to Biologic Drugs in the Treatment of Psoriasis

Evaluating Pharmacists’ Role In Veterinary Medication Management and Education

Drug Safety Agents Using Graphs and Ontologies

Signal to Safety: Unpacking the Pharmacovigilance Program of India (PVPI)

Suspect screening strategy reveals that illegal addition of drugs to fishery inputs is the main cause of drug residue problems in quality and safety of aquatic products in China

Excipient toxicity and tolerability in self-emulsifying drug delivery systems: insights from cell-based assays

Prevalence and Trends of Adulterants Detected in Products Sampled by Sarawak Pharmacy Enforcement Branch

Disproportionality analysis of semaglutide-associated bile-duct cancer: A vigibase study

Drug-associated tongue discoloration: a comprehensive assessment of USFDA adverse event reporting system using disproportionality analysis

Sex-disparate safety profile of Obinutuzumab: a pharmacovigilance analysis using the FDA adverse event reporting system

Rapid analytical screening of pharmaceuticals using UV-activated fluorescence fingerprints

Impact of Different Dosage Forms of Orally Administered Chinese Herbal Medicine on Treatment and Adverse Effect Estimates in Randomized Controlled Trials: A Meta-Epidemiological Study

Disproportionality analysis of drug-associated progressive multifocal leukoencephalopathy using spontaneous reports: A 20-year signal detection study based on the FAERS database

50 contenedores refuerzan la lucha contra el comercio ilegal de medicamentos vencidos o falsificados

Structure-Based Prediction of QT Prolongation Risk Using Graph Neural Networks: An Integrative Approach Combining In Vitro hERG Assays and Pharmacovigilance Data

Development of a non-genetic risk prediction model for allopurinol-induced severe cutaneous adverse drug reactions: a multicenter retrospective observational study

Artificial intelligence in pharmacy predicting adverse drug reactions

Impact of two decades of humanitarian and development assistance and the projected mortality consequences of current defunding to 2030: retrospective evaluation and forecasting analysis

Childhood Vaccinations: Public Health and Individual Rights

Antibiotic Use in Infancy May Set Path for Weight Gain

Comparative Safety of Advanced Therapies for Crohn Disease

Drug Used for Enlarged Prostate Tied to High Glaucoma Risk

A risk to child health: confusion and concern over changes to US vaccine policy

Four in ten cancer cases could be prevented globally

National and State Societal Costs of Schizophrenia in the US in 2024

Cancer Incidence and Mortality With Aspirin in Older Adults. Follow-Up of the ASPREE Trial

ADHD Treatment Linked to Higher Adult BMI, Slight Height Loss

Why Skin Toxicity Remains Common in Modern Cancer Therapies

Global pharmacovigilance analysis of antimicrobials used in periodontal therapy: safety profiles of minocycline, doxycycline, and chlorhexidine

Medication Errors: Year in Review

PHS urges caution following reports of increased harm from changes in Scotland’s drug supply

Fixed Drug Eruptions in Malagasy Children: Clinical Observations and Characteristics

An interpretable machine learning framework for adverse drug reaction prediction from drug-target interactions

Integrated precision medicine and artificial intelligence in healthcare

Development of a Data-Driven Prediction Model of Adverse Drug Reactions Using Large-Scale Medical Information and Machine Learning

How is AI developing in pharmacovigilance?

Digemid alerta sobre falsificación de Kitadol Migraña e incauta lotes: conoce cómo identificarlo

When I use a word . . . Artificial intelligence—predicting and detecting adverse drug reactions

Integration of materiovigilance in Unani medicine: A step towards patient safety

DEA Operation Meltdown Shuts Down Hundreds of Illegal Online Pharmacies

Adverse events related to buspirone: a real-world pharmacovigilance study using the FAERS database

Class-level drug safety surveillance in hospital practice: A pharmacovigilance analysis of 84 therapeutic subclasses from a South Asian tertiary care center

Safety Actions Common With Fast-Track Cancer Drugs

Beyond the Bookshelf: Transforming Drug Information Resources through Digital Innovation

Exploring adverse events associated with vosoritide monotherapy: Insights from the FDA Adverse Event Reporting System

Cardiac disorders associated with compound long-acting bronchodilators for inhalation: a pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS) database

Are We Missing Dangerous Drug Interactions? Pharmacist-Led Telehealth Raises Red Flags in Oncology Care

Pediatric IBD: Combination Therapy Linked to Increased Skin Infection Risk

Efficacy and safety of delayed thrombolysis for ischemic stroke within 4.5–24 h: A systematic review and meta-analysis of randomized controlled trials

Inteligencia artificial en medicina: una guía ética y práctica para la asistencia sanitaria, la investigación y la docencia

Overview of counterfeiting in performance-enhancing drugs used in enhanced bodybuilding

Preliminary Quality Evaluation of New Generic Brands of Ciprofloxacin

El Invima alerta sobre la venta ilegal de cápsulas “anti-alopecia”

We need a standardized North American acetylcysteine dosing regimen for the treatment of paracetamol (acetaminophen) poisoning

Reducing delays in time-critical medications for Parkinson's disease: a multifaceted, multiprofessional quality improvement project

FDA Requests Removal of Suicidal Ideation Warning From GLP-1 RA Medications

Rethinking anti-cancer drug discovery: the evolution from polypharmacy to unified drug units

Drug-associated deep vein thrombosis: a disproportionality analysis of the FDA adverse event reporting system (FAERS) database